{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:30:44Z","timestamp":1789471844749,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are key regulators of gene expression and play a crucial role in cancer progression. Recent studies have highlighted miR-423-5p as a potential modulator in hepatocellular carcinoma (HCC), especially in patients responding to sorafenib treatment. A functional interaction with the oncogenic lncRNA MALAT-1 has been hypothesized, suggesting a regulatory mechanism that may influence tumor aggressiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To investigate this interaction, we analyzed in silico patient datasets to correlate miR-423-5p and MALAT-1 expression with overall survival (OS) and disease free survival (DFS). Stable overexpression of miR-423-5p and MALAT-1 was achieved in HCC cell lines (HepG2, Hep3B, and SNU387) using a lentiviral transduction system. Functional assays were performed to assess proliferation, migration, invasion, and clonogenic potential. The interaction between miR-423-5p and MALAT-1 was confirmed by RNA immunoprecipitation (RIP), followed by transcriptomic analysis using next-generation sequencing (NGS). Mitochondrial activity was evaluated using the Seahorse Mito Stress Test to measure oxygen consumption rate (OCR) and ATP production. In vivo experiments in orthotopic mouse models were performed to assess tumor growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patient data analysis revealed that high miR-423-5p expression correlated with a less aggressive tumor phenotype and improved survival, while MALAT-1 was associated with poorer prognosis. In vitro, miR-423-5p overexpression reduced MALAT-1 levels and significantly impaired proliferation, migration, and invasion. NGS analysis identified transcriptomic changes linked to tumor progression and metabolic shift. The Seahorse Mito Stress Test demonstrated decreased cellular respiration and ATP production upon miR-423-5p overexpression. In vivo, both tumors derived from miR-423-5p-overexpressing cells and MALAT-1 downregulation by ASO GapmeR evidenced a significantly reduced growth compared to controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest, for the first time, that miR-423-5p acts as a tumor suppressor affecting mitochondrial metabolism through MALAT-1 downregulation in HCC. This regulatory axis represents a potential therapeutic target for precision medicine approaches in liver cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03524-2","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:41:45Z","timestamp":1759236105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction"],"prefix":"10.1186","volume":"44","author":[{"given":"Marco","family":"Bocchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia Maria","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Porru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Irace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Tufano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Misso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Amodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Scrima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Simeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Chianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Altucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Desiderio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Regad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Caraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Zappavigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"12","key":"3524_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20(12):864\u201384. https:\/\/doi.org\/10.1038\/s41571-023-00825-3.","journal-title":"Nat Rev Clin Oncol."},{"key":"3524_CR2","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2147\/JHC.S476439","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Lei J, Ma H, Zuo S. Impact of Type of Lenvatinib Resistance on Prognosis and Second-Line Regimen in Patients with Virus-Associated HCC. J Hepatocellular Carcinoma. 2024;11:1507\u201317. https:\/\/doi.org\/10.2147\/JHC.S476439.","journal-title":"J Hepatocellular Carcinoma."},{"issue":"23","key":"3524_CR3","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.3390\/cancers16233944","volume":"16","author":"AG Ermi","year":"2024","unstructured":"Ermi AG, Sarkar D. Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance. Cancers. 2024;16(23):3944. https:\/\/doi.org\/10.3390\/cancers16233944.","journal-title":"Cancers."},{"issue":"1","key":"3524_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma Nat Rev Dis Primers. 2021;7(1):6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","journal-title":"Hepatocellular carcinoma. Nat Rev Dis Primers."},{"issue":"4","key":"3524_CR5","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jhep.2021.07.004","volume":"75","author":"J Bruix","year":"2021","unstructured":"Bruix J, Chan SL, Galle PR, Rimassa L, Sangro B. Systemic treatment of hepatocellular carcinoma: An EASL position paper. J Hepatol. 2021;75(4):960\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2021.07.004.","journal-title":"J Hepatol."},{"issue":"15","key":"3524_CR6","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450\u201362. https:\/\/doi.org\/10.1056\/NEJMra1713263.","journal-title":"N Engl J Med."},{"key":"3524_CR7","doi-asserted-by":"publisher","unstructured":"Cai Y, Chen J, Zhang M, Zhang Y, Wang X, et al. LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2\/$$\\beta$$-catenin activation via interacting with hnRNPC. J Exp Clin Cancer Res. 2022;41(1):335. https:\/\/doi.org\/10.1186\/s13046-022-02544-6.","DOI":"10.1186\/s13046-022-02544-6"},{"issue":"5","key":"3524_CR8","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM. The Role of Non-coding RNAs in Oncology. Cell. 2019;179(5):1033\u201355. https:\/\/doi.org\/10.1016\/j.cell.2019.10.017.","journal-title":"Cell."},{"issue":"1","key":"3524_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5\u201318. https:\/\/doi.org\/10.1038\/nrc.2017.99.","journal-title":"Nat Rev Cancer."},{"issue":"1","key":"3524_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-023-02718-w","volume":"42","author":"C Bergamini","year":"2023","unstructured":"Bergamini C, Leoni I, Rizzardi N, Melli M, Galvani G, Coada CA, et al. MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma. J Exp Clin Cancer Res. 2023;42(1):145. https:\/\/doi.org\/10.1186\/s13046-023-02718-w.","journal-title":"J Exp Clin Cancer Res."},{"issue":"3","key":"3524_CR11","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.3892\/mmr.2017.8291","volume":"17","author":"H Li","year":"2018","unstructured":"Li H, Wang Y, Xu Q, Wang Y, Wang Y, Wang Y, et al. miR-373 suppresses gastric cancer metastasis by downregulating vimentin. Mol Med Rep. 2018;17(3):4027\u201334. https:\/\/doi.org\/10.3892\/mmr.2017.8291.","journal-title":"Mol Med Rep."},{"issue":"2","key":"3524_CR12","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3892\/etm.2018.6288","volume":"16","author":"W Jia","year":"2018","unstructured":"Jia W, Yu T, An Q, Cao X, Pan H. MicroRNA-423-5p inhibits colon cancer growth by promoting caspase-dependent apoptosis. Exp Ther Med. 2018;16(2):1225\u201331. https:\/\/doi.org\/10.3892\/etm.2018.6288.","journal-title":"Exp Ther Med."},{"issue":"1","key":"3524_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13046-021-02233-w","volume":"41","author":"C Ferri","year":"2022","unstructured":"Ferri C, Di Biase A, Bocchetti M, Zappavigna S, Wagner S, Le Vu P, et al. MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer. J Exp Clin Cancer Res. 2022;41(1):20. https:\/\/doi.org\/10.1186\/s13046-021-02233-w.","journal-title":"J Exp Clin Cancer Res."},{"issue":"3","key":"3524_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","volume":"24","author":"G Arun","year":"2018","unstructured":"Arun G, Diermeier SD, Spector DL. Therapeutic Targeting of Long Non-Coding RNAs in Cancer. Trends Mol Med. 2018;24(3):257\u201377. https:\/\/doi.org\/10.1016\/j.molmed.2018.01.001.","journal-title":"Trends Mol Med."},{"issue":"2","key":"3524_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/cancers11020216","volume":"11","author":"Y Sun","year":"2019","unstructured":"Sun Y, Ma L. New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis. Cancers (Basel). 2019;11(2):216. https:\/\/doi.org\/10.3390\/cancers11020216.","journal-title":"Cancers (Basel)."},{"issue":"1","key":"3524_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-018-0606-4","volume":"11","author":"N Amodio","year":"2018","unstructured":"Amodio N, Raimondi L, Juli G, Stamato MA, Caracciolo D, Tagliaferri P, et al. MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches. J Hematol Oncol. 2018;11(1):63. https:\/\/doi.org\/10.1186\/s13045-018-0606-4.","journal-title":"J Hematol Oncol."},{"issue":"3","key":"3524_CR17","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3892\/ol.2016.4138","volume":"11","author":"D Ren","year":"2016","unstructured":"Ren D, Li H, Li R, Sun J, Guo P, Han H, et al. Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications. Oncol Lett. 2016;11(3):1621\u201330. https:\/\/doi.org\/10.3892\/ol.2016.4138.","journal-title":"Oncol Lett."},{"issue":"17","key":"3524_CR18","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1111\/jcmm.17835","volume":"27","author":"T Wang","year":"2023","unstructured":"Wang T, Li N, Yuan L, Zhao M, Li G, Chen Y, et al. MALAT1\/miR-185-5p mediated high glucose-induced oxidative stress, mitochondrial injury and cardiomyocyte apoptosis via the RhoA\/ROCK pathway. J Cell Mol Med. 2023;27(17):2495\u2013506. https:\/\/doi.org\/10.1111\/jcmm.17835.","journal-title":"J Cell Mol Med."},{"key":"3524_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.omtn.2020.09.040","volume":"23","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhou L, Li H, Sun T, Wen X, Li X, et al. Nuclear-Encoded lncRNA MALAT1 Epigenetically Controls Metabolic Reprogramming in Hepatocellular Carcinoma Cells through the Mitophagy Pathway. Mol Ther Nucleic Acids. 2020;23:264\u201376. https:\/\/doi.org\/10.1016\/j.omtn.2020.09.040.","journal-title":"Mol Ther Nucleic Acids."},{"key":"3524_CR20","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1038\/mtna.2015.8","volume":"4","author":"P Stiuso","year":"2015","unstructured":"Stiuso P, Ferranti P, De Simone V, Alfano L, Del Vecchio L, Cigliano A, et al. MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib. Mol Ther Nucleic Acids. 2015;4:e233. https:\/\/doi.org\/10.1038\/mtna.2015.8.","journal-title":"Mol Ther Nucleic Acids."},{"issue":"1","key":"3524_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13046-022-02297-2","volume":"41","author":"MR Braghini","year":"2022","unstructured":"Braghini MR, Lo Re O, Romito I, Fernandez-Barrena MG, Barbaro B, Pomella S, et al. Epigenetic remodelling in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41(1):107. https:\/\/doi.org\/10.1186\/s13046-022-02297-2.","journal-title":"J Exp Clin Cancer Res."},{"issue":"1","key":"3524_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3892\/ol.2019.11182","volume":"19","author":"B Sun","year":"2020","unstructured":"Sun B, Liu C, Li H, Zhang L, Luo G, Liang S, et al. Research progress on the interactions between long non-coding RNAs and microRNAs in human cancer. Oncol Lett. 2020;19(1):595\u2013605. https:\/\/doi.org\/10.3892\/ol.2019.11182.","journal-title":"Oncol Lett."},{"issue":"12","key":"3524_CR23","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1080\/15476286.2017.1358347","volume":"14","author":"X Zhang","year":"2017","unstructured":"Zhang X, Hamblin MH, Yin KJ. The long noncoding RNA Malat 1: Its physiological and pathophysiological functions. RNA Biol. 2017;14(12):1705\u201314. https:\/\/doi.org\/10.1080\/15476286.2017.1358347.","journal-title":"RNA Biol."},{"issue":"6","key":"3524_CR24","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.3892\/etm.2018.6015","volume":"15","author":"X Tang","year":"2018","unstructured":"Tang X, Zeng X, Huang Y, Chen S, Lin F, Yang G, et al. miR-423-5p serves as a diagnostic indicator and inhibits the proliferation and invasion of ovarian cancer. Exp Ther Med. 2018;15(6):4723\u201330. https:\/\/doi.org\/10.3892\/etm.2018.6015.","journal-title":"Exp Ther Med."},{"issue":"1","key":"3524_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/ijms24010617","volume":"24","author":"A Luce","year":"2023","unstructured":"Luce A, Lombardi A, Ferri C, Zappavigna S, Tathode MS, Miles AK, et al. A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells. Int J Mol Sci. 2023;24(1):617. https:\/\/doi.org\/10.3390\/ijms24010617.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"3524_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1245\/s10434-023-14402-6","volume":"31","author":"K Wakizaka","year":"2024","unstructured":"Wakizaka K, Kamiyama T, Kakisaka T, Orimo T, Nagatsu A, Aiyama T, et al. Expression of Wnt5a and ROR2, Components of the Noncanonical Wnt-Signaling Pathway, is Associated with Tumor Differentiation in Hepatocellular Carcinoma. Ann Surg Oncol. 2024;31(1):262\u201371. https:\/\/doi.org\/10.1245\/s10434-023-14402-6.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"3524_CR27","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.3390\/ijms24054996","volume":"24","author":"T Gao","year":"2023","unstructured":"Gao T, Yang X, Fujisawa M, Ohara T, Wang T, Tomonobu N, et al. SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells. Int J Mol Sci. 2023;24(5):4996. https:\/\/doi.org\/10.3390\/ijms24054996.","journal-title":"Int J Mol Sci."},{"issue":"9","key":"3524_CR28","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/labinvest.2010.105","volume":"90","author":"T Mamiya","year":"2010","unstructured":"Mamiya T, Yamazaki K, Masugi Y, Mori T, Effendi K, Du W, et al. Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab Investig. 2010;90(9):1339\u201345. https:\/\/doi.org\/10.1038\/labinvest.2010.105.","journal-title":"Lab Investig."},{"key":"3524_CR29","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Luque J, Bertran E, Crosas-Molist E, Maiques O, Malfettone A, Caja L, et al. Downregulation of Epidermal Growth Factor Receptor in hepatocellular carcinoma facilitates Transforming Growth Factor-\u03b2\u2013induced epithelial to amoeboid transition. Cancer Lett. 2019;464:15\u201324. https:\/\/doi.org\/10.1016\/j.canlet.2019.08.011.","DOI":"10.1016\/j.canlet.2019.08.011"},{"issue":"5","key":"3524_CR30","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/cas.14787","volume":"112","author":"J Wan","year":"2021","unstructured":"Wan J, Liu Y, Long F, Tian J, Zhang C. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a\/Ror2 signaling. Cancer Sci. 2021;112(5):1707\u201322. https:\/\/doi.org\/10.1111\/cas.14787.","journal-title":"Cancer Sci."},{"issue":"4","key":"3524_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/17246008211043128","volume":"36","author":"X Wen","year":"2021","unstructured":"Wen X, Du J, Wang X. Circ_0039411 promotes papillary thyroid carcinoma development through mediating the miR-423-5p\/SOX4 signaling. Int J Biol Markers. 2021;36(4):10\u201320. https:\/\/doi.org\/10.1177\/17246008211043128.","journal-title":"Int J Biol Markers."},{"key":"3524_CR32","doi-asserted-by":"publisher","first-page":"103358","DOI":"10.1016\/j.redox.2024.103358","volume":"77","author":"Y Lin","year":"2024","unstructured":"Lin Y, Tsai Y, Li C, Wei T, Wang J, Lin B, et al. Overexpression of NUDT16L1 sustains proper function of mitochondria and leads to ferroptosis insensitivity in colorectal cancer. Redox Biol. 2024;77:103358. https:\/\/doi.org\/10.1016\/j.redox.2024.103358.","journal-title":"Redox Biol."},{"issue":"1","key":"3524_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12964-022-00900-9","volume":"21","author":"X Kong","year":"2023","unstructured":"Kong X, Patel NA, Chalfant CE, Cooper DR. Ceramide synthesis regulates biogenesis and packaging of exosomal MALAT1 from adipose-derived stem cells, increases dermal fibroblast migration and mitochondrial function. Cell Commun Signal. 2023;21(1):221. https:\/\/doi.org\/10.1186\/s12964-022-00900-9.","journal-title":"Cell Commun Signal."}],"updated-by":[{"DOI":"10.1186\/s13046-025-03562-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000}}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03524-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03524-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03524-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:34:15Z","timestamp":1762497255000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03524-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3524"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03524-2","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\"The original online version of this article was revised: the authors identified an error in Figure 8\".","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13046-025-03562-w","URL":"https:\/\/doi.org\/10.1186\/s13046-025-03562-w","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal procedures were in compliance with the national and international directives (D.L. 4 March 2014, no. 26; directive 2010\/63\/EU of the European Parliament and of the council; Guide for the Care and Use of Laboratory Animals, United States National Research Council, 2011) and approved by the Italian Ministry of Health (authorization n. 346\/2020-PR, released on 29-04-2020). Mice were maintained in a barrier facility on high-efficiency particulate air HEPA-filtered racks and received food and water ad libitum.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}